Lv5
838 积分 2022-07-21 加入
Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges
13天前
已完结
Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies
17天前
已完结
Bispecific antibodies in lung cancer: From molecular engineering to clinical breakthroughs and translational challenges
17天前
已关闭
The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective
17天前
已完结
Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges
17天前
已完结
Low-Dose Stereotactic Body Radiation Therapy–Based Radiation Therapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable Non-Small Cell Lung Cancer: A Phase 1b Study
27天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
1个月前
已完结
The antibody–drug conjugate landscape
1个月前
已完结
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY
1个月前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
1个月前
已完结
皖公网安备34019202002308
